Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNNC1 | P63316 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 3/20 | 0.43 |
| ▸ | FAAH | O00519 | 3/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2007721 | 1.00 | TNNC1 (0.48) | TNNC1PPARAFAAHEPHX2CYP4F2 | |
| SCHEMBL8498445 | 0.88 | CYP4F2 (0.54) | TNNC1PPARACYP4F2CYP4A11PPARG | |
| SCHEMBL8498447 | 0.88 | CYP4F2 (0.54) | TNNC1PPARACYP4F2CYP4A11PPARG | |
| SCHEMBL6037040 | 0.87 | CYP4F2 (0.44) | CYP4F2CYP4A11 | |
| SCHEMBL27892640 | 0.86 | PPARA (0.53) | TNNC1PPARAPPARG | |
| SCHEMBL28801237 | 0.84 | PPARA (0.51) | TNNC1PPARACYP4F2CYP4A11PPARG | |
| SCHEMBL16974817 | 0.84 | PPARA (0.42) | TNNC1PPARAFAAHEPHX2PPARG | |
| SCHEMBL9836110 | 0.83 | PPARA (0.50) | TNNC1PPARAPPARG | |
| SCHEMBL677026 | 0.83 | TNNC1 (0.40) | TNNC1PPARAFAAHEPHX2CYP4F2 | |
| SCHEMBL9836116 | 0.83 | PPARA (0.50) | TNNC1PPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7960571-B2 | Silicon-based cross-coupling reagent and production method of organic compound using the same | KYOTO UNIVERSITY (JP) | 2011-06-14 | — | — | US | disclosed |
| US-20090069577-A1 | Silicon-Based Cross-Coupling Reagent and Production Method of Organic Compound Using the Same | KYOTO UNIVERSITY (JP) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069577-A1 | Silicon-Based Cross-Coupling Reagent and Production Method of Organic Compound Using the Same | DNMT1, TET3, CTCF | TNNC1 3618/4885PPARA 4334/4885FAAH 3904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.